Company research / ISRG

Intuitive Surgical Inc (ISRG)

SEC name INTUITIVE SURGICAL INC · CIK 0001035267 · Nasdaq · Orthopedic, Prosthetic & Surgical Appliances & Supplies

  • Sector Manufacturing
  • Incorporated DE
  • Fiscal year ends Dec 31

For the year ended 2025-12-31, Intuitive Surgical Inc reported revenue of $10.06B. Revenue grew 20.5% from the prior annual period. Over the twelve months to 2026-06-30, revenue was $11.03B.

Key ratios (year ended 2025-12-31)

66.0%
Gross margin
29.3%
Operating margin
28.4%
Net margin
16.0%
Return on year-end equity
20.5%
Revenue growth (YoY)

Beyond the statements

Follow the company.

Explore new filings, reported insider transactions and company relationships.

Open company research ↗

Latest selected filing: Form 4 (ownership change) · 2026-10-13

Headquarters locality: Sunnyvale · View on map

Annual financials

Annual flows and balances are grouped by their actual period end. Select a figure to open its SEC filing. n/a means a matching observation is unavailable. Free cash flow is operating cash flow minus capital expenditures, and EBITDA is operating income plus depreciation and amortization, for the same period, computed by TickerFacts.

The first column covers the twelve months to 2026-06-30 from the latest quarterly report: flows are the last fiscal year plus this year to date minus the same months a year earlier, and balances are as of that date. Per-share figures are annual only.

Stock splits: 3-for-1, first reflected in a filing dated 2017-10-20; 3-for-1, first reflected in a filing dated 2021-10-20. Figures are as filed: per-share figures and share counts last reported before a split are on the old share basis, so changes and growth rates across a split are not shown. Splits are read from the filings' own restatements, so a share conversion in a merger or reorganization shows up the same way.

Period endedTTM to
2026-06-30
2025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-31
Revenue$11.03B$10.06B$8.35B$7.12B$6.22B$5.71B$4.36B$4.48B$3.72B$3.14B$2.71B
Cost of Revenue$3.68B$3.42B$2.72B$2.39B$2.03B$1.75B$1.50B$1.37B$1.12B$936.20M$813.60M
Gross Profit$7.36B$6.64B$5.63B$4.73B$4.20B$3.96B$2.86B$3.11B$2.60B$2.20B$1.89B
R&D Expense$1.41B$1.31B$1.15B$998.80M$879.00M$671.00M$595.10M$557.30M$418.10M$328.60M$239.60M
Operating Income$3.45B$2.95B$2.35B$1.77B$1.58B$1.82B$1.05B$1.37B$1.20B$1.06B$949.70M
Net Income$3.14B$2.86B$2.32B$1.80B$1.32B$1.70B$1.06B$1.38B$1.13B$670.90M$738.30M
EPS (Diluted)n/a$7.87$6.42$5.03$3.65$4.66$2.94$3.85$9.49$5.77$6.26
Total Assets$20.88B$20.46B$18.74B$15.44B$12.97B$13.55B$11.17B$9.73B$7.85B$5.78B$6.49B
Total Liabilities$2.58B$2.52B$2.21B$2.04B$1.86B$1.60B$1.41B$1.45B$1.16B$996.40M$709.10M
Shareholders' Equity$18.17B$17.82B$16.43B$13.31B$11.04B$11.90B$9.73B$8.26B$6.68B$4.78B$5.78B
Cash & Equivalents$2.76B$3.37B$2.03B$2.75B$1.58B$1.29B$1.62B$1.17B$857.90M$648.20M$1.04B
Operating Cash Flow$3.71B$3.03B$2.42B$1.81B$1.49B$2.09B$1.48B$1.60B$1.17B$1.14B$1.09B
Capital Expenditures$483.80M$539.80M$1.11B$1.06B$532.40M$339.50M$341.50M$425.60M$187.40M$190.70M$53.90M
Free Cash Flow$3.22B$2.49B$1.30B$749.60M$958.40M$1.75B$1.14B$1.17B$982.20M$953.20M$1.03B
Share Repurchases$3.56B$2.30B$0$416.30M$2.61B$0$134.30M$269.50M$0$2.27B$42.50M
Shares Outstanding353.90M355.10M356.60M352.30M350.00M357.70M353.10M116.00M114.50M112.30M116.40M
Weighted Average Diluted Sharesn/a362.70M362.00M357.40M362.00M365.80M361.00M358.40M118.80M116.30M117.90M
EPS (Basic)n/a$8.00$6.54$5.12$3.72$4.79$3.02$3.98$9.92$6.01$6.43

Price chart

Chart and quotes by TradingView. Exchange coverage and delays vary.

Open chart on TradingView